{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:01:08Z","timestamp":1793246468185,"version":"4.5.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myelodysplastic syndrome (MDS) is a hematopoietic stem-cell disorder characterized by trilineage dysplasia and susceptibility to acute myelogenous leukemia (AML). Analysis of molecular basis of MDS has been hampered by the heterogeneity of the disease. Recently, mutations of the transcription factor AML1\/RUNX1 have been identified in 15% to 40% of MDS\u2013refractory anemia with excess of blasts (RAEB) and MDS\/AML. We performed mouse bone marrow transplantation (BMT) using bone marrow cells transduced with the AML1 mutants. Most mice developed MDS and MDS\/AML-like symptoms within 4 to 13 months after BMT. Interestingly, among integration sites identified, Evi1 seemed to collaborate with an AML1 mutant harboring a point mutation in the Runt homology domain (D171N) to induce MDS\/AML with an identical phenotype characterized by marked hepatosplenomegaly, myeloid dysplasia, leukocytosis, and biphenotypic surface markers. Collaboration between AML1-D171N and Evi1 was confirmed by a BMT model where coexpression of AML1-D171N and Evi1 induced acute leukemia of the same phenotype with much shorter latencies. On the other hand, a C-terminal truncated AML1 mutant (S291fsX300) induced pancytopenia with erythroid dysplasia in transplanted mice, followed by progression to MDS-RAEB or MDS\/AML. Thus, we have developed a useful mouse model of MDS\/AML that should help in the understanding of the molecular basis of MDS and the progression of MDS to overt leukemia.<\/jats:p>","DOI":"10.1182\/blood-2007-01-068346","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T21:07:20Z","timestamp":1200085640000},"page":"4297-4308","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":138,"title":["AML1 mutations induced MDS and MDS\/AML in a mouse BMT model"],"prefix":"10.1182","volume":"111","author":[{"given":"Naoko","family":"Watanabe-Okochi","sequence":"first","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Kitaura","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Harada","sequence":"additional","affiliation":[{"name":"International Radiation Information Center, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Komeno","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nosaka","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111715164011800_B1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/asheducation-2003.1.176","article-title":"Myelodysplastic syndrome.","author":"Mufti","year":"2003","journal-title":"Am Soc Hematol Educ Program"},{"key":"2019111715164011800_B2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","article-title":"Myelodysplasia.","volume":"340","author":"Heaney","year":"1999","journal-title":"N Engl J Med"},{"key":"2019111715164011800_B3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00062752-199502040-00008","article-title":"Myelodysplastic syndrome.","volume":"2","author":"Legare","year":"1995","journal-title":"Curr Opin Hematol"},{"key":"2019111715164011800_B4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/327430a0","article-title":"A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.","volume":"327","author":"Hirai","year":"1987","journal-title":"Nature"},{"key":"2019111715164011800_B5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V71.1.256.256","article-title":"Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression myelodysplastic syndrome.","volume":"71","author":"Hirai","year":"1988","journal-title":"Blood"},{"key":"2019111715164011800_B6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00062752-200207000-00003","article-title":"Role of FLT3 in leukemia.","volume":"9","author":"Gilliland","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"2019111715164011800_B7","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1172\/JCI24225","article-title":"The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice.","volume":"115","author":"Schessl","year":"2005","journal-title":"J Clin Invest"},{"key":"2019111715164011800_B8","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1182\/blood.V91.9.3134","article-title":"Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.","volume":"91","author":"Okuda","year":"1998","journal-title":"Blood"},{"key":"2019111715164011800_B9","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/blood.V96.6.2108","article-title":"Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.","volume":"96","author":"Rhoades","year":"2000","journal-title":"Blood"},{"key":"2019111715164011800_B10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1535-6108(02)00016-8","article-title":"Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.","volume":"1","author":"Higuchi","year":"2002","journal-title":"Cancer Cell"},{"key":"2019111715164011800_B11","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.0400751101","article-title":"Stem cell expression of the AML1\/ETO fusion protein induces a myeloproliferative disorder in mice.","volume":"101","author":"Fenske","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715164011800_B12","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1128\/MCB.22.15.5506-5517.2002","article-title":"Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.","volume":"22","author":"de Guzman","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019111715164011800_B13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI200522725","article-title":"Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.","volume":"115","author":"Ono","year":"2005","journal-title":"J Clin Invest"},{"key":"2019111715164011800_B14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI21716","article-title":"EVI1 induces myelodysplastic syndrome in mice.","volume":"114","author":"Buonamici","year":"2004","journal-title":"J Clin Invest"},{"key":"2019111715164011800_B15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"2019111715164011800_B16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"key":"2019111715164011800_B17","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","article-title":"Disruption of the Cbfa2 gene causes necrosis and hematorrhaging in the central nervous system and blocks definitive hematopoiesis.","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715164011800_B18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm997","article-title":"AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.","volume":"10","author":"Ichikawa","year":"2004","journal-title":"Nat Med"},{"key":"2019111715164011800_B19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"2019111715164011800_B20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood.V99.4.1364","article-title":"In vitro analyses of known and novel RUNX1\/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.","volume":"99","author":"Michaud","year":"2002","journal-title":"Blood"},{"key":"2019111715164011800_B21","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V93.6.1817.406k36_1817_1824","article-title":"Biallelic and heterozygous point mutations in the runt domain of the AML1\/PEBP2alphaB gene associated with myeloblastic leukemias.","volume":"93","author":"Osato","year":"1999","journal-title":"Blood"},{"key":"2019111715164011800_B22","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood.V96.8.2862","article-title":"High incidence of biallelic point mutations in the Runt domain of the AML1\/PEBP2alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.","volume":"96","author":"Preudhomme","year":"2000","journal-title":"Blood"},{"key":"2019111715164011800_B23","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V96.9.3154","article-title":"Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis.","volume":"96","author":"Imai","year":"2000","journal-title":"Blood"},{"key":"2019111715164011800_B24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/gcc.10031","article-title":"Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7.","volume":"34","author":"Langabeer","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"2019111715164011800_B25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2002-04-1010","article-title":"Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome\/acute myeloid leukemia.","volume":"101","author":"Harada","year":"2003","journal-title":"Blood"},{"key":"2019111715164011800_B26","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2003-09-3074","article-title":"High incidence of somatic mutations in the AML1\/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.","volume":"103","author":"Harada","year":"2004","journal-title":"Blood"},{"key":"2019111715164011800_B27","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/sj.onc.1207779","article-title":"Point mutations in the RUNX1\/AML1 gene: another actor in RUNX leukemia.","volume":"23","author":"Osato","year":"2004","journal-title":"Oncogene"},{"key":"2019111715164011800_B28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0609.2004.00363.x","article-title":"Somatic point mutations in RUNX1\/CBFA2\/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia.","volume":"74","author":"Steensma","year":"2005","journal-title":"Eur J Haematol"},{"key":"2019111715164011800_B29","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2004-02-0754","article-title":"Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation.","volume":"104","author":"Christiansen","year":"2004","journal-title":"Blood"},{"key":"2019111715164011800_B30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2141.2005.05793.x","article-title":"Haploinsufficiency of Runx1\/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.","volume":"131","author":"Yamashita","year":"2005","journal-title":"Br J Haematol"},{"key":"2019111715164011800_B31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(88)91175-0","article-title":"Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines.","volume":"54","author":"Morishita","year":"1988","journal-title":"Cell"},{"key":"2019111715164011800_B32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/MCB.8.1.301","article-title":"Identification of a common ecotropic viral integration site, Evi1, in the DNA of AKXD murine myeloid tumors.","volume":"8","author":"Mucenski","year":"1988","journal-title":"Mol Cell Biol"},{"key":"2019111715164011800_B33","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood-2005-03-1115","article-title":"Recurrent retroviral vector integration at the Mds1\/Evi1 locus in nonhuman primate hematopoietic cells.","volume":"106","author":"Calmels","year":"2005","journal-title":"Blood"},{"key":"2019111715164011800_B34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1105063","article-title":"Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.","volume":"308","author":"Kustikova","year":"2005","journal-title":"Science"},{"key":"2019111715164011800_B35","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood-2004-11-4535","article-title":"Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.","volume":"105","author":"Modlich","year":"2005","journal-title":"Blood"},{"key":"2019111715164011800_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","article-title":"Evi1 and hematopoietic disorders: history and perspectives.","volume":"368","author":"Nucifora","year":"2006","journal-title":"Gene"},{"key":"2019111715164011800_B37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/nar\/gkh013","article-title":"RTCGD: retroviral tagged cancer gene database.","volume":"32","author":"Akagi","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2019111715164011800_B38","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood-2006-08-041202","article-title":"Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.","volume":"109","author":"Jin","year":"2007","journal-title":"Blood"},{"key":"2019111715164011800_B39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: an efficient and stable system for transient packaging of retroviruses.","volume":"7","author":"Morita","year":"2000","journal-title":"Gene Ther"},{"key":"2019111715164011800_B40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","article-title":"Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics.","volume":"31","author":"Kitamura","year":"2003","journal-title":"Exp. Hematol"},{"key":"2019111715164011800_B41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V100.1.238","article-title":"Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.","volume":"100","author":"Kogan","year":"2002","journal-title":"Blood"},{"key":"2019111715164011800_B42","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1158\/0008-5472.CAN-07-0075","article-title":"Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.","volume":"67","author":"Slape","year":"2007","journal-title":"Cancer Res"},{"key":"2019111715164011800_B43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1006\/bbrc.1998.9588","article-title":"Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation.","volume":"252","author":"Wimmer","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111715164011800_B44","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/nar\/18.10.2887","article-title":"Anovel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucl.","volume":"18","author":"Riley","year":"1990","journal-title":"Acids Res"},{"key":"2019111715164011800_B45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1101\/gr.1.1.39","article-title":"Vectorette PCR: a novel approach to genome walking.","volume":"1","author":"Arnold","year":"1991","journal-title":"PCR Methods Appl"},{"key":"2019111715164011800_B46","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1371\/journal.pmed.0040172","article-title":"Isoform-specific potentiation of stem and progenitor cell engraftment by AML1\/RUNX1.","volume":"4","author":"Tsuzuki","year":"2007","journal-title":"PLoS Med"},{"key":"2019111715164011800_B47","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","article-title":"Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.","volume":"92","author":"Riviere","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715164011800_B48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2141.2001.02569.x","article-title":"EVI1 expression in acute myeloid leukaemia.","volume":"112","author":"Langabeer","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111715164011800_B49","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.onc.1207143","article-title":"Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1\/MDS1\/EVI1 with BCR\/ABL in the induction of acute myelogenous leukemia in mice.","volume":"23","author":"Cuenco","year":"2004","journal-title":"Oncogene"},{"key":"2019111715164011800_B50","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/sj.leu.2401887","article-title":"Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice.","volume":"14","author":"Louz","year":"2000","journal-title":"Leukemia"},{"key":"2019111715164011800_B51","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2006-04-014845","article-title":"High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.","volume":"108","author":"Heuser","year":"2006","journal-title":"Blood"},{"key":"2019111715164011800_B52","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1073\/pnas.030421197","article-title":"Human AML1\/MDS1\/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML.","volume":"97","author":"Cuenco","year":"2000","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/8\/4297\/1301639\/zh800808004297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/8\/4297\/1301639\/zh800808004297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T15:16:55Z","timestamp":1574003815000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/8\/4297\/24651\/AML1-mutations-induced-MDS-and-MDSAML-in-a-mouse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-01-068346","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1109004.566171","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}